Tag: Pharma acquisition news
Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise
India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More
AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics
Pharma giant AstraZeneca has closed the previously announced acquisition of Neogene Therapeutics, a US-based clinical-stage biotechnology company. Neogene Therapeutics is engaged in the discovery, development, ... Read More
AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn
AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More
Chiesi Farmaceutici to acquire biopharma company Amryt Pharma for $1.5bn
Chiesi Farmaceutici, an Italian biopharmaceuticals and healthcare group, has agreed to acquire Amryt Pharma, a commercial-stage biopharmaceutical company, in an all-cash transaction valued at around ... Read More
Acelyrin boosts immunology pipeline through acquisition of ValenzaBio
Acelyrin has acquired ValenzaBio, a privately held clinical-stage biopharmaceutical company, in an all-stock deal. With the acquisition of ValenzaBio, the US- based late-stage clinical biopharma ... Read More
Moderna to acquire Japanese biotech firm OriCiro Genomics for $85m
Moderna has agreed to acquire OriCiro Genomics, a Japanese biotech firm involved in developing cell-free synthesis and amplification of plasmid DNAs for applications in gene ... Read More
Berkeley Lights to acquire biotechnology company IsoPlexis to form PhenomeX
Berkeley Lights, a US-based life sciences tools company, will acquire IsoPlexis, a Nasdaq-listed biotechnology company, in an all-stock deal worth $57.8 million. IsoPlexis empowers labs ... Read More
Gilead’s Kite to acquire CAR T-therapies developer Tmunity Therapeutics
Kite, an arm of Gilead Sciences, has agreed to acquire Tmunity Therapeutics, a Philadelphia-based clinical-stage biotech company focused on next-generation CAR T-therapies and technologies, for ... Read More
KKR to acquire Japanese CDMO Bushu Pharmaceuticals from BPEA EQT
American global investment company Kohlberg Kravis Roberts & Co (KKR) will acquire all shares of Bushu Pharmaceuticals from Asian private equity firm BPEA EQT for ... Read More
GRI Bio, Vallon Pharmaceuticals to merge for advancing NKT cell regulators
GRI Bio, a privately held clinical stage biotech company, will merge with a wholly-owned subsidiary of Nasdaq-listed Vallon Pharmaceuticals in an all-stock transaction. The combined ... Read More
